BIO-Europe Spring 2019: Themis Bioscience Harnesses Measles Vector For Immune Modulation

 
• By Mike Ward

Themis Bioscience CEO Erich Tauber outlined the company’s work in immune modulation in an interview at BIO-Europe Spring 2019.

Video interview
Themis Bioscience CEO Erich Tauber speaks to Scrip

More from R&D

More from Scrip